Sentinel-Lymph-Node Multicenter Trials

• Published in: Seminars in nuclear medicine Vol. 50; no. 1; pp. 56 - 74
• Main Authors: Moncayo, Valeria M., Grady, Erin E., Alazraki, Naomi P., Aarsvold, John N.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.2020
• Subjects: Clinical Trials as Topic; Humans; Multicenter Studies as Topic; Neoplasms - diagnostic imaging; Neoplasms - pathology; Neoplasms - surgery; Sentinel Lymph Node Biopsy - methods
• ISSN: 0001-2998; 1558-4623; 1558-4623
• DOI: 10.1053/j.semnuclmed.2019.10.001

Well executed multicenter clinical trials often provide significant evidence and support for, or against, foundational aspects of clinical procedures perceived to improve clinical management of a medical condition. In this review, discussed are reports of multicenter clinical trials designed to investigate sentinel lymph node biopsy procedures in seven types of cancer: breast, melanoma, head and neck, gastric, colon, uterine, and vulvar—with focus on the most recent reports of the hypotheses, objectives, parameters, data, results, implications, and impacts of the included trials. Such trials generally enroll more subjects, in shorter time periods, than do single-center studies. Such studies generally also have greater diversities among investigator practitioners and investigative environments than do single-center studies. The greater number of subjects provides more power to statistical analyses performed in such studies. The more rapid accrual usually results in data being more consistently acquired. The diversities of practitioners and environments may produce results that are more conservative than might be obtained from more “focused” studies; however, diversities in a study often identify implicitly results that are more robust—that is results applicable by more practitioners and applicable in more environments.